As filed with the Securities and Exchange Commission on July 22, 1997
Registration No. ___-_____
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FORM 8-A
FOR REGISTRATION OF CERTAIN
CLASSES OF SECURITIES PURSUANT
TO SECTION 12(b) OR 12(g) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
-----------------------------------------
DURA PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
DELAWARE 95-3645543
----------------------- -----------------------------------
(State of incorporation (I.R.S. Employer Identification No.)
or organization)
5880 PACIFIC CENTER BOULEVARD
SAN DIEGO, CALIFORNIA 92121
(Address of Principal Executive Offices) (Zip Code)
If this form relates to the If this form relates to the
registration of a class of registration of a class of
debt securities and is debt securities and is to
effective upon filing pursuant become effective
to General Instruction A(c)(1) simultaneously with the
please check the following effectiveness of a concurrent
box. / / registration statement under
the Securities Act of 1933
pursuant to General
Instruction A(c)(2) please
check the following box. / /
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
------------------- ------------------------------
Not applicable Not applicable
Securities to be registered pursuant to Section 12(g) of the Act:
Convertible Subordinated Notes due 2002
- -------------------------------------------------------------------------------
(Title of class)
- -------------------------------------------------------------------------------
(Title of class)
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the Convertible Subordinated Notes due 2002
(the "Notes") to be registered hereunder, including all of the
information required by Item 202 of Regulation S-K, is contained
under the heading "Description of Notes" in the prospectus included
in the Company's Registration Statement on Form S-3 filed with the
Securities and Exchange Commission under the Securities Act of 1933
(Registration No. 333-30851), as amended from time to time (the
"Registration Statement"), which description is incorporated herein
by reference.
ITEM 2. EXHIBITS.
The following exhibits to this Registration Statement on Form 8-A are
incorporated by reference to the documents specified which have been or will
be filed with the Securities and Exchange Commission.
1. Form of Indenture, filed as Exhibit 4.1 to the Company's
Registration Statement (Registration No. 333-30851).
2. Form of Note, filed as Exhibit 4.1 to the Company's
Registration Statement (Registration No. 333-30851).
3. Certificate of Incorporation, filed as Exhibit 3.2 to the
Company's Quarterly Report on Form 10-Q for the quarter
ended June 30, 1997.
4. Bylaws of the Company, filed as Exhibit 3.1 to the
Company's Quarterly Report on Form 10-Q for the quarter
ended June 30, 1997.
2.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the Registrant has duly caused this registration
statement to be signed on its behalf by the undersigned, thereto duly
authorized.
DURA PHARMACEUTICALS, INC.
Date: July 22, 1997 By: /s/ CAM L. GARNER
--------------------------
Cam L. Garner
Chairman, President and
Chief Executive Officer
3.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
EXHIBITS
TO
FORM 8-A
UNDER
SECURITIES EXCHANGE ACT OF 1934
DURA PHARMACEUTICALS, INC.
EXHIBIT INDEX
-------------
The following exhibits to this Registration Statement on Form 8-A are
incorporated by reference to the documents specified which have been or will
be filed with the Securities and Exchange Commission.
EXHIBIT
NUMBER
- -------
1. Form of Indenture, filed as Exhibit 4.1 to the Company's Registration
Statement (Registration No. 333-30851).
2. Form of Note, filed as Exhibit 4.1 to the Company's Registration
Statement (Registration No. 333-30851).
3. Certificate of Incorporation, filed as Exhibit 3.2 to the Company's
Quarterly Report on Form 10-Q for the quarter ended June 30, 1997.
4. Bylaws of the Company, filed as Exhibit 3.1 to the Company's Quarterly
Report on Form 10-Q for the quarter ended June 30, 1997.